Geetha Chittoor

Geetha Chittoor

Auto-generated profile, based on publicly available information

Geetha Chittoor

Department of Population Health Sciences, Geisinger, Danville, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2021 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
JPJoseph Park
Joseph Park
ALAnastasia M. Lucas
Anastasia M. Lucas
XZXinyuan Zhang
Xinyuan Zhang
KCKumardeep Chaudhary
Kumardeep Chaudhary
JCJudy H. Cho
Judy H. Cho
DRDaniel J Rader
Daniel J Rader

1 August 2022 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
MLMikyeong Lee
Mikyeong Lee
THTianxiao Huan
Tianxiao Huan
DMDaniel L. McCartney
Daniel L. McCartney
GCGeetha Chittoor
Geetha Chittoor
MVMaaike De Vries
Maaike De Vries
SLStephanie London
Stephanie London
Rationale: Methylation integrates factors present at birth and modifiable across the lifespan that can influence pulmonary function. Studies are limited in scope and replication. Objectives: To conduct large-scale epigenome-wide meta-analyses of blood DNA methylation and pulmonary function. Methods: Twelve cohorts analyzed associations of methylation at cytosine-phosphate-guanine probes (CpGs), using Illumina 450K or EPIC/850K arrays, with FEV1, FVC, and FEV1/FVC. We performed multiancestry epigenome-wide meta-analyses (total of 17,503 individuals; 14,761 European, 2,549 African, and 193 Hispanic/Latino ancestries) and interpreted results using integrative epigenomics. Measurements and Main Results: We identified 1,267 CpGs (1,042 genes) differentially methylated (false discovery rate, <0.025) in relation to FEV1, FVC, or FEV1/FVC, including 1,240 novel and 73 also related to chronic obstructive pulmonary disease (1,787 cases). We found 294 CpGs unique to European or African ancestry and 395 CpGs unique to never or ever smokers. The majority of significant CpGs correlated with nearby gene expression in blood. Findings were enriched in key regulatory elements for gene function, including accessible chromatin elements, in both blood and lung. Sixty-nine implicated genes are targets of investigational or approved drugs. One example novel gene highlighted by integrative epigenomic and druggable target analysis is TNFRSF4. Mendelian randomization and colocalization analyses suggest that epigenome-wide association study signals capture causal regulatory genomic loci. Conclusions: We identified numerous novel loci differentially methylated in relation to pulmonary function; few were detected in large genome-wide association studies. Integrative analyses highlight functional relevance and potential therapeutic targets. This comprehensive discovery of potentially modifiable, novel lung function loci expands knowledge gained from genetic studies, providing insights into lung pathogenesis.

26 September 2025 in International Journal of Obesity
Verified
Journal Article
Open access
PDF file
HXHanfei Xu
Hanfei Xu
SGShreyash Gupta
Shreyash Gupta
IDIan Dinsmore
Ian Dinsmore
AKAbbey Kollu
Abbey Kollu
ACAnne Marie Cawley
Anne Marie Cawley
CLChing-Ti Liu
Ching-Ti Liu
Background: Genome-wide association studies (GWAS) have identified numerous body mass index (BMI) loci. However, most underlying mechanisms from risk locus to BMI remain unknown. Leveraging omics data through integrative analyses could provide more comprehensive views of biological pathways on BMI. Methods: We analyzed genotype and blood gene expression data from up to 5619 samples in the Framingham Heart Study (FHS). Using 3992 single-nucleotide polymorphisms (SNPs) at 97 BMI loci and 1408 transcripts within 1 Mb, we performed separate association analyses of transcript with BMI and SNP with transcript ( P BMI and P SNP , respectively) and then a correlated meta-analysis between the full summary data sets ( P META ). Transcripts were prioritized if we identified transcripts that met Bonferroni-corrected significance within each omic, showed stronger associations in the correlated meta-analysis than each omic, and had corresponding SNPs in the SNP-transcript-BMI association that were at least nominally associated with BMI in FHS data. We tested for generalization of identified association in a Hispanic ancestry sample of blood gene expression data and other samples in hypothalamus, nucleus accumbens, liver, and visceral adipose tissue (VAT) with significant threshold: P META < 0.05 & P META < P SNP & P META < P BMI . Results: Among 308 significant SNP-transcript-BMI associations, we identified seven genes ( NT5C2 , GSTM3 , SNAPC3 , SPNS1 , TMEM245 , YPEL3 , and ZNF646 ) in five association regions. We generalized results for SNAPC3 and YPEL3 in Hispanic ancestry sample, for YPEL3 in the nucleus accumbens, ZNF646 and GSTM3 in VAT, and NT5C2 , SNAPC3 , TMEM245 , YPEL3 , and ZNF646 in liver. Conclusion: The identified genes help link the genetic variation at obesity-risk loci to biological mechanisms and health outcomes, thus translating GWAS findings to function.